![]() | Only 14 pages are availabe for public view |
Abstract The role of hepatitis viruses (B, D and C) was investigated among 40 infants and children with CLD presenting to the Pediatric Hepatology Outpatient Clinic New Children’s Hospital, Cairo university. The patients were classified into 4 groups [bilharzial group] (group I); [Cirrhotic group] (group II); [CAR] (group III); [CPH] (group IV) . They were 32 males and 8 females, with age range between 4-16 years. In addition, 32 age and sex matched healthy children served as a control group (group V) . All CLD cases were properly clinically examined, investigated including urine and stools analyses, CBC, liver function tests, abdominal sonography, upper G.I.I. endoscopy, and aspiration liver biopsy in some cases. Sera and saliva of these children were examined for HBV markers (HB. Ag, anti HBc’ anti HB.)t HDV antibodies (anti HDV) and HCV antibodies (anti HCV) . 165 Hepatitis C antibodies were detected in 25% of cases; hepatitis B virUs markers were present in 30% and 75% of HB. Ag +ve cases had concomitant anti HDV antibodies. HB. Ag in saliva was detected in 33.3% of cases of bilharzial group, 50% in cirrhotic group, 25% in CAR group and nil in CPH group. Anti-HCV could not be detected in any case in saliva. 35.5% of our CLD cases had schistosomal infection. The percentage of HB~ Ag in the bilharzial group was 30.75%, while 25% of such cases had HCV antibodies. The highest incidence of blood transfusion (70%) was in those with HCV antibodies, while 33.3% of our delta cases had past history of blood transfusion and 18.75% of those with HB. Ag +ve had past history of blood transfusion. Concerning control cases (32) HB. Ag was positive in 9.37% of them and none of our controls had evidence of HCV infection. The failure to detect HCV infection can be explained by the younger age group of our controls and the limited number of studied cases. |